InspireMD Research Development vs Non Recurring Analysis

NSPR Stock

USD 2.67 0.02 0.74%

InspireMD financial indicator trend analysis is infinitely more than just investigating InspireMD recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InspireMD is a good investment. Please check the relationship between InspireMD Research Development and its Non Recurring accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

Research Development vs Non Recurring

Research Development vs Non Recurring Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InspireMD Research Development account and Non Recurring. At this time, the significance of the direction appears to have pay attention.

The correlation between InspireMD's Research Development and Non Recurring is -0.79. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Non Recurring in the same time period over historical financial statements of InspireMD, assuming nothing else is changed. The correlation between historical values of InspireMD's Research Development and Non Recurring is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of InspireMD are associated (or correlated) with its Non Recurring. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Recurring has no effect on the direction of Research Development i.e., InspireMD's Research Development and Non Recurring go up and down completely randomly.

Correlation Coefficient

-0.79

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Research Development

Non Recurring

Most indicators from InspireMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Tax Provision is relatively stable compared to the past year. As of 08/05/2025, Sales General And Administrative To Revenue is likely to grow to 2.31, while Issuance Of Capital Stock is likely to drop slightly above 1.5 M.

	2022	2023	2024	2025 (projected)
Other Operating Expenses	23.9M	27.3M	40.5M	42.5M
Total Revenue	5.2M	6.2M	7.0M	4.6M

Other Operating Expenses Total Revenue

InspireMD fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross	Short Term Debt	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable
Total Assets		0.85	0.28	0.98	-0.75	-0.66	0.69	0.97	0.24	0.88	0.6	0.12	1.0	-0.31	-0.2	0.85	0.45	0.59	0.0	0.72	0.87	-0.32	0.62	0.85	-0.41	0.46
Other Current Liab	0.85		0.42	0.77	-0.6	-0.58	0.69	0.76	0.22	0.92	0.43	0.32	0.82	-0.12	0.02	0.94	0.59	0.56	0.13	0.89	0.92	-0.17	0.48	0.91	-0.22	0.39
Total Current Liabilities	0.28	0.42		0.14	0.09	-0.25	0.15	0.29	-0.16	0.33	0.29	0.64	0.27	-0.46	0.53	0.38	0.47	0.22	0.29	0.35	0.31	0.65	0.4	0.27	0.23	0.56
Total Stockholder Equity	0.98	0.77	0.14		-0.8	-0.73	0.62	0.96	0.19	0.85	0.69	-0.08	0.97	-0.35	-0.39	0.8	0.29	0.49	-0.17	0.59	0.86	-0.42	0.67	0.84	-0.57	0.39
Net Debt	-0.75	-0.6	0.09	-0.8		0.64	-0.79	-0.78	-0.1	-0.72	-0.58	0.2	-0.75	0.14	0.43	-0.72	-0.34	-0.49	0.07	-0.46	-0.73	0.51	-0.5	-0.73	0.6	-0.36
Retained Earnings	-0.66	-0.58	-0.25	-0.73	0.64		-0.26	-0.73	0.27	-0.73	-0.93	0.39	-0.63	0.62	0.56	-0.74	-0.11	-0.07	0.43	-0.25	-0.78	0.11	-0.84	-0.8	0.84	-0.29
Cash	0.69	0.69	0.15	0.62	-0.79	-0.26		0.64	0.23	0.65	0.15	0.35	0.7	0.03	0.16	0.69	0.61	0.64	0.34	0.68	0.62	-0.3	0.19	0.61	-0.07	0.54
Cash And Short Term Investments	0.97	0.76	0.29	0.96	-0.78	-0.73	0.64		0.13	0.82	0.69	0.05	0.97	-0.43	-0.23	0.82	0.47	0.58	0.02	0.59	0.83	-0.26	0.69	0.8	-0.48	0.51
Common Stock Total Equity	0.24	0.22	-0.16	0.19	-0.1	0.27	0.23	0.13		0.01	-0.17	0.3	0.24	0.58	0.05	0.09	0.21	0.5	0.33	0.56	0.04	-0.47	-0.06	0.08	0.28	-0.07
Common Stock Shares Outstanding	0.88	0.92	0.33	0.85	-0.72	-0.73	0.65	0.82	0.01		0.58	0.05	0.84	-0.29	-0.22	0.94	0.43	0.45	-0.12	0.72	0.99	-0.18	0.54	0.95	-0.44	0.37
Other Stockholder Equity	0.6	0.43	0.29	0.69	-0.58	-0.93	0.15	0.69	-0.17	0.58		-0.36	0.59	-0.6	-0.58	0.59	0.02	0.14	-0.41	0.14	0.64	-0.16	0.92	0.66	-0.81	0.33
Total Liab	0.12	0.32	0.64	-0.08	0.2	0.39	0.35	0.05	0.3	0.05	-0.36		0.14	0.17	0.91	0.16	0.69	0.56	0.82	0.52	0.01	0.33	-0.18	-0.03	0.76	0.48
Total Current Assets	1.0	0.82	0.27	0.97	-0.75	-0.63	0.7	0.97	0.24	0.84	0.59	0.14		-0.32	-0.18	0.82	0.45	0.61	0.03	0.69	0.84	-0.33	0.61	0.81	-0.39	0.49
Common Stock	-0.31	-0.12	-0.46	-0.35	0.14	0.62	0.03	-0.43	0.58	-0.29	-0.6	0.17	-0.32		0.15	-0.28	0.05	0.21	0.33	0.2	-0.29	-0.41	-0.58	-0.3	0.45	-0.38
Short Long Term Debt Total	-0.2	0.02	0.53	-0.39	0.43	0.56	0.16	-0.23	0.05	-0.22	-0.58	0.91	-0.18	0.15		-0.13	0.54	0.26	0.78	0.22	-0.28	0.53	-0.42	-0.32	0.86	0.37
Non Current Assets Total	0.85	0.94	0.38	0.8	-0.72	-0.74	0.69	0.82	0.09	0.94	0.59	0.16	0.82	-0.28	-0.13		0.6	0.54	0.07	0.77	0.96	-0.17	0.62	0.97	-0.41	0.43
Non Currrent Assets Other	0.45	0.59	0.47	0.29	-0.34	-0.11	0.61	0.47	0.21	0.43	0.02	0.69	0.45	0.05	0.54	0.6		0.78	0.8	0.66	0.41	0.13	0.16	0.39	0.3	0.53
Net Receivables	0.59	0.56	0.22	0.49	-0.49	-0.07	0.64	0.58	0.5	0.45	0.14	0.56	0.61	0.21	0.26	0.54	0.78		0.69	0.68	0.43	-0.36	0.18	0.4	0.18	0.51
Non Current Liabilities Total	0.0	0.13	0.29	-0.17	0.07	0.43	0.34	0.02	0.33	-0.12	-0.41	0.82	0.03	0.33	0.78	0.07	0.8	0.69		0.37	-0.14	0.13	-0.28	-0.16	0.69	0.38
Inventory	0.72	0.89	0.35	0.59	-0.46	-0.25	0.68	0.59	0.56	0.72	0.14	0.52	0.69	0.2	0.22	0.77	0.66	0.68	0.37		0.72	-0.21	0.21	0.7	0.08	0.36
Property Plant And Equipment Gross	0.87	0.92	0.31	0.86	-0.73	-0.78	0.62	0.83	0.04	0.99	0.64	0.01	0.84	-0.29	-0.28	0.96	0.41	0.43	-0.14	0.72		-0.21	0.61	0.98	-0.51	0.34
Short Term Debt	-0.32	-0.17	0.65	-0.42	0.51	0.11	-0.3	-0.26	-0.47	-0.18	-0.16	0.33	-0.33	-0.41	0.53	-0.17	0.13	-0.36	0.13	-0.21	-0.21		-0.06	-0.25	0.39	0.07
Other Liab	0.62	0.48	0.4	0.67	-0.5	-0.84	0.19	0.69	-0.06	0.54	0.92	-0.18	0.61	-0.58	-0.42	0.62	0.16	0.18	-0.28	0.21	0.61	-0.06		0.66	-0.65	0.32
Property Plant And Equipment Net	0.85	0.91	0.27	0.84	-0.73	-0.8	0.61	0.8	0.08	0.95	0.66	-0.03	0.81	-0.3	-0.32	0.97	0.39	0.4	-0.16	0.7	0.98	-0.25	0.66		-0.55	0.3
Current Deferred Revenue	-0.41	-0.22	0.23	-0.57	0.6	0.84	-0.07	-0.48	0.28	-0.44	-0.81	0.76	-0.39	0.45	0.86	-0.41	0.3	0.18	0.69	0.08	-0.51	0.39	-0.65	-0.55		-0.01
Accounts Payable	0.46	0.39	0.56	0.39	-0.36	-0.29	0.54	0.51	-0.07	0.37	0.33	0.48	0.49	-0.38	0.37	0.43	0.53	0.51	0.38	0.36	0.34	0.07	0.32	0.3	-0.01

Click cells to compare fundamentals

InspireMD Account Relationship Matchups

InspireMD fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	17.8M	39.7M	24.7M	47.6M	46.8M	49.1M
Other Current Liab	3.1M	3.0M	4.0M	4.5M	6.4M	6.7M
Total Current Liabilities	3.7M	4.3M	5.1M	6.0M	7.7M	4.4M
Total Stockholder Equity	12.2M	33.5M	17.4M	39.5M	36.1M	37.9M
Net Debt	(11.6M)	(10.8M)	(3.0M)	(9.6M)	(16.6M)	(15.7M)
Retained Earnings	(168.2M)	(183.1M)	(201.6M)	(221.5M)	(253.5M)	(240.8M)
Cash	12.6M	12.0M	4.6M	9.6M	18.9M	19.9M
Cash And Short Term Investments	12.6M	34.0M	17.8M	39.0M	34.6M	36.4M
Common Stock Shares Outstanding	1.5M	7.3M	7.9M	24.3M	41.9M	44.0M
Liabilities And Stockholders Equity	17.8M	39.7M	24.7M	47.6M	46.8M	49.1M
Other Stockholder Equity	180.3M	216.6M	219.0M	261M	289.6M	149.8M
Total Liab	5.6M	6.2M	7.3M	8.1M	10.7M	7.6M
Total Current Assets	15.3M	37.1M	21.3M	44.2M	40.5M	42.5M
Short Long Term Debt Total	999K	1.2M	1.6M	1.6M	2.3M	2.9M
Non Current Assets Total	2.4M	2.6M	3.3M	3.5M	6.3M	6.6M
Non Currrent Assets Other	725K	905K	856K	951K	1.6M	1.6M
Net Receivables	945K	1.4M	1.2M	1.8M	2.3M	1.4M
Non Current Liabilities Total	1.9M	1.8M	2.2M	2.1M	3.0M	2.5M
Inventory	1.4M	1.1M	1.6M	2.1M	2.6M	2.7M
Short Term Debt	400K	420K	419K	557K	542K	900.5K
Other Liab	729K	910K	1.1M	995K	1.1M	738.6K
Accounts Payable	236K	893K	659K	939K	1.3M	797.1K
Other Assets	586K	725K	905K	856K	984.4K	506K
Other Current Assets	334K	522K	655K	3.0M	1.1M	1.1M
Property Plant Equipment	547K	448K	1.7M	2.5M	2.8M	3.0M
Net Tangible Assets	5.4M	12.2M	33.5M	17.4M	20.0M	21.0M
Net Invested Capital	12.2M	33.5M	17.4M	39.5M	36.1M	21.4M

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

InspireMD Research Development vs Non Recurring Analysis

Research Development vs Non Recurring

Research Development vs Non Recurring Correlation Analysis

Correlation Coefficient

Research Development

Non Recurring

InspireMD fundamental ratios Correlations

InspireMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

InspireMD fundamental ratios Accounts

Additional Tools for InspireMD Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 0.99	Common Stock Shares Outstanding
Total Stockholder Equity	+ 0.98	Total Assets
Property Plant And Equipment Net	+ 0.98	Property Plant And Equipment Gross
Cash And Short Term Investments	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Total Stockholder Equity

Other Stockholder Equity	- 0.93	Retained Earnings
Other Liab	- 0.84	Retained Earnings
Current Deferred Revenue	- 0.81	Other Stockholder Equity
Property Plant And Equipment Net	- 0.8	Retained Earnings
Net Debt	- 0.8	Total Stockholder Equity
Cash	- 0.79	Net Debt